CompanyProfileNomu
ActionsMiral Dental Clinics Co.
- Nomu - Parallel Market
- Health Care Equipment & Svc
Stats Overview
-
Prev. Close 102.00
-
Open 101.20
-
High 106.00
-
Low 100.00
-
No. Of Trades 28
-
Avg. Trade size* 24
-
Volume Traded 663
-
Value Traded 67,971.20
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Trade Updates
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select A Maximum Of 5 Companies
LoginPortletPopupv2
ActionsAddtoWatchlistv2
ActionsAnnouncmentandCorporateAction
Actions- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
---|
CompanyProfileNomuv2Financials
Actions- Announcements & Corporate Actions
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Semi-Annual
Balance Sheet | ||||
---|---|---|---|---|
Total Assets | - | - | - | - |
Total Liabilities | - | - | - | - |
Total Shareholders Equity (After Deducting the Minority Equity) | - | - | - | - |
Total Liabilities and Shareholders Equity | - | - | - | - |
Statement of Income | ||||
Total Revenue (Sales/Operating) | - | - | - | - |
Net Profit (Loss) before Zakat and Tax | - | - | - | - |
Zakat and Income Tax | - | - | - | - |
Net Profit (Loss) after Zakat and Tax | - | - | - | - |
Total Comprehensive Income | - | - | - | - |
Profit (Loss) per Share | - | - | - | - |
Cash Flows | ||||
Net Cash From Operating Activities | - | - | - | - |
Net Cash From Investing Activities | - | - | - | - |
Net Cash From Financing Activities | - | - | - | - |
Cash and Cash Equivalents, Beginning of the Period | - | - | - | - |
Cash and Cash Equivalents, End of the Period | - | - | - | - |
All Figures in | ||||
All Currency In | ||||
Last Update Date |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
Balance Sheet | 2024-06-30 | |||
---|---|---|---|---|
Total Assets |
69,145
|
- | - | - |
Total Liabilities |
19,721
|
- | - | - |
Total Shareholders Equity (After Deducting the Minority Equity) |
49,424
|
- | - | - |
Total Liabilities and Shareholders Equity |
69,145
|
- | - | - |
Statement of Income | 2024-06-30 | |||
Total Revenue (Sales/Operating) |
33,977
|
- | - | - |
Net Profit (Loss) before Zakat and Tax |
7,146
|
- | - | - |
Zakat and Income Tax |
-605
|
- | - | - |
Net Profit (Loss) after Zakat and Tax |
6,541
|
- | - | - |
Total Comprehensive Income |
6,541
|
- | - | - |
Profit (Loss) per Share |
3.27
|
- | - | - |
Cash Flows | 2024-06-30 | |||
Net Cash From Operating Activities |
11,932
|
- | - | - |
Net Cash From Investing Activities |
-20,911
|
- | - | - |
Net Cash From Financing Activities |
-265
|
- | - | - |
Cash and Cash Equivalents, Beginning of the Period |
25,439
|
- | - | - |
Cash and Cash Equivalents, End of the Period |
16,195
|
- | - | - |
All Figures in | Thousands | |||
All Currency In | SAR | |||
Last Update Date | 2024-09-01 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
Miral Medical Clinics Company is one of the French national companies providing medical and cosmetic dental services through its two branches in the city of Riyadh. For further procedures regarding activating the company and its services, please visit Section No. 3 of the registration document.
Company History
Miral Medical Clinics Company (the Company or Issuer) was established as a sole proprietorship under the Commercial Registration1010180168 issued by the City of Riyadh on 06-25-1423 AH corresponding to 09/03/2002 AD, and on 03-13-1443 AH corresponding to 19 10-2021 ADMinisterial Resolution No. 623 was issued authorizing the transformation of the company from a limited liability company to a closed joint stock company, and on 03/20/1443 AH corresponding to 10-26-2021 AD the General Assembly of the company shareholders the Transformation Assembly approved the The company was converted from a limited liability company to a closed joint stock company, and on 03/22/1443 AH corresponding to 10/28/2021 AD Ministerial Resolution No 652 was issued approving the announcement of the company transformation from a limited liability company to a closed joint stock company, and on 02/28/1444 AH 09/24/2022 AD the company current capital is twenty million 20,000,000 Saudi riyals, divided into two million 2,000,000 ordinary shares, the value of each share being ten10 Saudi riyals.The company current capital is twenty million 20,000,000 Saudi riyals divided into two million 2,000,000 fully paid shares, the value of each share being ten10Saudi riyals.The company current capital is twenty million 20,000,000 Saudi riyals divided into two million 2,000,000 fully paid shares, the value of each share being ten 10 Saudi riyals.
Company Bylaws
Equity Profile
- Authorized Capital (SAR) 20,000,000
- Issued Shares 2,000,000
- Paid Up Capital (SAR) 20,000,000
- Par Value/Share 10
- Paid Up Value/Share 10
Last Update :2024-05-29
Investment limits
There are no investment limits on the company's shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on Company's bylaw and the issued Instructions by related regulators and supervisory authorities.
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
Ahmad Fathi Dahdouh
Company Address:
Riyadh Olaia Tahlia St.
Contact Details:
Telephone: 0114620444
Fax: 0114661078
Email: investors@miraldental.com
Company Website:
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.